Document v6X8RDyZvbyDLrEQB71exZ

# THE UPJOHN COMPANY K A LA M A ZO O , M IC HIG A N 49001 TELEPHONE (616) 382-4000 M EDICAL SERVICES Offu c of KENNE. IH B H A A S D V M July 9, 1976 Hearing Clerk Food and Drug Administration Room A-65 5600 Fishers Lane Rockville, Maryland 20852 Dear Sir: In compliance with the Federal Register Notice, Volume AO, Number 51, March 14, 1975, page 11865, titled "Asbestos-form Particles in Drugs for Parenteral Injection", we are supplying the attached memo as an updated report for replacement of asbestos filters. Very truly yours , THE UPJOHN COMPANY HRA/KBH/ct att. Harry R. Allen, M .D . Manager, FDA Liaison Domestic Pharmaceutical Med ica1 Affai rs yS/^su/ S&P03 y As reported in May there are two lots of S.A.S. Diurnal Penicillin Readimixed on stability. Lot #1 was manufactured according to the current production procedure except for using the Scott BNR filter. Lot #2 was manufactured according to the current production procedure . except for substitution of Centrolex P for Centrolex H and for using I the Scott BNR filter. No new studies are planned. \ o lad